Additionally, we also assessed the link between RHBDF2 and clinicopathological parameters and found that RHBDF2 overexpression was significantly linked to tumor histology, stage, lymph node metastasis and TP53 mutation. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.